For pharmaceutical and other regulated buyers, PG USP procurement is about much more than price and availability. Recent FDA enforcement keeps supplier controls, incoming-component testing, traceability, and impurity risk firmly in the purchasing discussion.

What Happened?

In a warning letter dated July 27, 2026, FDA raised concerns about inadequate testing of high-risk incoming components and discussed retained propylene glycol lots and appropriate USP identity and impurity testing.

The agency stressed the importance of scientific data showing that incoming components meet specifications before use. FDA also continues to provide guidance to drug manufacturers, compounders, repackagers, and suppliers on testing high-risk components such as propylene glycol for diethylene glycol (DEG) and ethylene glycol (EG).

Why This Matters for PG USP K

A supplier Certificate of Analysis is not a complete substitute for a manufacturer's CGMP responsibilities. For purchasing teams, this places greater emphasis on supplier traceability, lot-specific records, USP compliance, DEG/EG controls, COAs, analytical data, and change-control procedures.

Kosher certification for PG USP K can be an important commercial requirement, but it is separate from pharmaceutical quality controls and should not be treated as a substitute for them.

What Buyers Should Watch

1  Supplier qualification and traceability. Understand the manufacturing source, supply-chain path, and controls behind the material.

2  Lot-specific documentation and testing. Align purchasing requirements with the quality unit's expectations for identity and DEG/EG controls.

3  Supplier or origin changes. A new vendor or manufacturing origin may require additional review or qualification before use.

GreenChem Takeaway

The key question when buying PG USP K is not simply whether a supplier can provide the material. Buyers also need to confirm that the sourcing file contains the quality records, testing data, traceability, and qualification details required by their quality system before the material is released for manufacturing.

For pharmaceutical and other regulated buyers, PG USP procurement is about much more than price and availability. Recent FDA enforcement keeps supplier controls, incoming-component testing, traceability, and impurity risk firmly in the purchasing discussion.

What Happened?

In a warning letter dated July 27, 2026, FDA raised concerns about inadequate testing of high-risk incoming components and discussed retained propylene glycol lots and appropriate USP identity and impurity testing.

The agency stressed the importance of scientific data showing that incoming components meet specifications before use. FDA also continues to provide guidance to drug manufacturers, compounders, repackagers, and suppliers on testing high-risk components such as propylene glycol for diethylene glycol (DEG) and ethylene glycol (EG).

Why This Matters for PG USP K

A supplier Certificate of Analysis is not a complete substitute for a manufacturer's CGMP responsibilities. For purchasing teams, this places greater emphasis on supplier traceability, lot-specific records, USP compliance, DEG/EG controls, COAs, analytical data, and change-control procedures.

Kosher certification for PG USP K can be an important commercial requirement, but it is separate from pharmaceutical quality controls and should not be treated as a substitute for them.

What Buyers Should Watch

1  Supplier qualification and traceability. Understand the manufacturing source, supply-chain path, and controls behind the material.

2  Lot-specific documentation and testing. Align purchasing requirements with the quality unit's expectations for identity and DEG/EG controls.

3  Supplier or origin changes. A new vendor or manufacturing origin may require additional review or qualification before use.

GreenChem Takeaway

The key question when buying PG USP K is not simply whether a supplier can provide the material. Buyers also need to confirm that the sourcing file contains the quality records, testing data, traceability, and qualification details required by their quality system before the material is released for manufacturing.